Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-02 @ 11:06 AM
Study NCT ID:
NCT04464967
Status:
WITHDRAWN
Last Update Posted:
2021-05-12
First Post:
2020-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
Sponsor:
NKGen Biotech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-02
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-01
First Submit QC Date:
None
Study First Post Date:
2020-07-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-10
Last Update Post Date:
2021-05-12
Last Update Post Date Type:
ACTUAL